Figure 3From: Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens Overview of the design for the RNA input study. RNA from 13 tissue samples was tested across and beyond the RNA input range specified for the assay.Back to article page